Furthermore, immunoblotting analysis demonstrated reduced NRF2 protein levels in the nuclear fraction of AD patients’ midfrontal cortex [190], indicating that NRF2-mediated transcription is not induced in neurons in AD. Here, NFE2L2 is linked to Alzheimer disease.